Quazepam
| Use attributes for filter ! | |
| Molar mass | 386. 795 g/mol |
|---|---|
| CAS ID | 36735-22-5 |
| Elimination half-life | 39 hours |
| Trade name | Doral |
| Metabolism | Hepatic |
| ATC code | N05CD10 (WHO) |
| Music groups | Flurazepam |
| Triazolam | |
| Flunitrazepam | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2173595 |
About Quazepam
Quazepam is a relatively long-acting benzodiazepine derivative drug developed by the Schering Corporation in the 1970s. Quazepam is indicated for the treatment of insomnia including sleep induction and sleep maintenance.